Acura Pharmaceuticals, Inc. (ACUR)

Market Cap	666.49K -85.5%
Revenue (ttm)	1.56M -56.2%
Net Income	-879.00K
EPS	-0.02
Shares Out	66.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120
Average Volume	2,560
Open	0.0100
Previous Close	0.0005
Day's Range	0.0100 - 0.0100
52-Week Range	0.0001 - 0.0200
Beta	69.55
RSI	84.12
Earnings Date	n/a

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUR

Financial Performance

In 2021, Acura Pharmaceuticals's revenue was $1.56 million, a decrease of -56.22% compared to the previous year's $3.57 million. Losses were -$879,000, -27.24% less than in 2020.